Lantheus Holdings Inc
$ 81.26
-2.17%
15 Jul - close price
- Market Cap 5,746,572,000 USD
- Current Price $ 81.26
- High / Low $ 83.32 / 80.88
- Stock P/E 23.66
- Book Value 16.84
- EPS 3.51
- Next Earning Report 2025-07-31
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.14 %
- ROE 0.24 %
- 52 Week High 122.83
- 52 Week Low 73.11
About
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
Analyst Target Price
$128.31
Quarterly Earnings
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-04-30 | 2025-02-20 | 2024-11-06 | 2024-07-31 | 2024-05-02 | 2024-02-22 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-02-23 | 2022-11-03 | 2022-08-04 |
| Reported EPS | 1.53 | 1.59 | 1.7 | 1.8 | 1.69 | 1.75 | 1.47 | 1.54 | 1.47 | 1.37 | 0.99 | 0.89 |
| Estimated EPS | 1.6539 | 1.5431 | 1.56 | 1.83 | 1.54 | 1.45 | 1.32 | 1.31 | 1.26 | 0.96 | 0.83 | 0.7 |
| Surprise | -0.1239 | 0.0469 | 0.14 | -0.03 | 0.15 | 0.3 | 0.15 | 0.23 | 0.21 | 0.41 | 0.16 | 0.19 |
| Surprise Percentage | -7.4914% | 3.0393% | 8.9744% | -1.6393% | 9.7403% | 20.6897% | 11.3636% | 17.5573% | 16.6667% | 42.7083% | 19.2771% | 27.1429% |
Next Quarterly Earnings
| Jun 2025 | Sep 2025 | |
|---|---|---|
| Reported Date | 2025-07-31 | 2025-10-30 |
| Fiscal Date Ending | 2025-06-30 | 2025-09-30 |
| Estimated EPS | 1.69 | 1.68 |
| Currency | USD | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LNTH
2025-07-04 19:00:26
Lantheus Holdings's LNTH short percent of float has risen 14.21% since its last report. The company recently reported that it has 9.13 million shares sold short, which is 17.36% of all regular shares that are available for trading.
2025-06-11 20:01:00
BEDFORD, Mass., June 11, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( the Company ) ( NASDAQ: LNTH ) , the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced the presentation of new ...
2025-05-12 20:36:00
SEATTLE, May 12, 2025 ( GLOBE NEWSWIRE ) -- Perspective Therapeutics, Inc. ( "Perspective," the "Company," "we," "us," and "our" ) ( NYSE AMERICAN: CATX ) , a radiopharmaceutical company that is pioneering advanced treatments for cancers throughout the body, today provided a business update and ...
2025-05-08 10:20:05
Style Box ETF report for ...
2025-05-07 12:10:18
U.S. stock futures were higher this morning, with the Dow futures gaining over 300 points on Wednesday. Shares of Sarepta Therapeutics, Inc. SRPT fell sharply in today's pre-market trading after the company reported a first-quarter adjusted EPS miss.
2025-05-06 20:01:00
Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite®
